-
Do Topical Steroids Lead to Glaucoma or Cataract?; Can Exenatide Prevent Glucocorticoid-Induced Hyperglycemia?; COPD: Beyond Pulmocentricity; Aspirin and Risk of Death from Cancer; Reducing Incontinence After Prostatectomy; Real-life Efficacy of Herpes Zoster Vaccine
-
While the human papillomavirus (HPV) vaccine has been approved for use in men, how many are open to receiving it? New research indicates men might be more willing to receive vaccination when they learn the vaccine can prevent cancer.
-
Findings from a new national report reflect an increase in the use of early medication abortion.
-
Many women might choose the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera) for its ease of use, but they might discontinue the method due to irregular bleeding.
-
-
Despite the important progress that has been made in obstetrics, in general, over the last 20 years, shoulder dystocia remains an enigma. Given the rising rate of maternal obesity and gestational diabetes, it is unlikely that the rate of this dangerous complication will be lowered in the near future.
-
Ova-301 was a large (n = 672), open-label phase III trial comparing pegylated liposomal doxorubicin (PLD) to combination PLD and trabectedin (PT) in women with recurrent ovarian cancer. The trial's overall population was previously reported and demonstrated a significant impact on PFS, without a significant improvement in OS.
-
In this issue: Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.
-
Obesity is a growing problem in the united states. the pun would be funny were it not for the adverse influence that the obesity epidemic has had on health care outcomes.
-
Recent investigation into the molecular pathogenesis of epithelial ovarian cancer has implicated two dominant phenotypes.